Granulocyte-Colony Stimulating Factor (G-CSF) for stroke: an individual patient data meta-analysis.

Thrombosis, Neuroinflammation, and Poststroke Infection: The Multifaceted Role of Neutrophils in Stroke. J Immunol Res (2017) 0.75

Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro. Stem Cell Res Ther (2017) 0.75

Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet (1997) 29.18

Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet (1991) 12.30

Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke (2009) 5.28

The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest (2005) 3.22

Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke (2003) 2.44

Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke (2013) 2.36

Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ (2006) 1.79

Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial. Stroke (2011) 1.74

Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation (2006) 1.49

G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab (2005) 1.46

AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke (2010) 1.19

Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: A systematic review. Brain Res Rev (2009) 1.18

Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Stroke (2006) 1.15

Effects of granulocyte-colony stimulating factor after stroke in aged rats. Stroke (2010) 1.11

The genomic response of the ipsilateral and contralateral cortex to stroke in aged rats. J Cell Mol Med (2008) 1.02

Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in rats. Stroke (2007) 1.01

Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke. J Stroke Cerebrovasc Dis (2009) 0.99

Brain repair by hematopoietic growth factors in a rat model of stroke. Stroke (2007) 0.98

Neurological and functional recovery in human stroke are associated with peripheral blood CD34+ cell mobilization. J Neurol (2007) 0.96

Preclinical models of stroke in aged animals with or without comorbidities: role of neuroinflammation. Biogerontology (2013) 0.95

Potentiation of neurogenesis and angiogenesis by G-CSF after focal cerebral ischemia in rats. Brain Res (2007) 0.95

Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke. J Neuroinflammation (2014) 0.88

Multimodal Approaches for Regenerative Stroke Therapies: Combination of Granulocyte Colony-Stimulating Factor with Bone Marrow Mesenchymal Stem Cells is Not Superior to G-CSF Alone. Front Aging Neurosci (2014) 0.87

Mobilization of CD34+ hematopoietic cells, colony-forming cells and long-term culture-initiating cells into the peripheral blood of patients with an acute cerebral ischemic insult. Cytotherapy (2008) 0.87

Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. Cochrane Database Syst Rev (2013) 0.87

Granulocyte-colony stimulating factor (G-CSF) in stroke patients with concomitant vascular disease--a randomized controlled trial. PLoS One (2011) 0.86

Granulocyte-colony stimulating factor inhibits neuronal apoptosis in a rat model of diabetic cerebral ischemia. Tohoku J Exp Med (2008) 0.85

Granulocyte colony-stimulating factor attenuates delayed tPA-induced hemorrhagic transformation in ischemic stroke rats by enhancing angiogenesis and vasculogenesis. J Cereb Blood Flow Metab (2014) 0.83

Mobilization of Stem Cells Using G-CSF for Acute Ischemic Stroke: A Randomized Controlled, Pilot Study. Stroke Res Treat (2011) 0.82

Granulocyte-colony-stimulating Factor for Acute Ischemic Stroke: A Randomized Controlled Trial (STEMTHER). Transl Stroke Res (2011) 0.81

The Efficacy and Safety of Granulocyte Colony-Stimulating Factor for Patients with Stroke. J Stroke Cerebrovasc Dis (2015) 0.81

G-CSF enhances stem cell proliferation in rat hippocampus after transient middle cerebral artery occlusion. Neurosci Lett (2007) 0.79

Granulocyte colony-stimulating factor and bone marrow mononuclear cells for stroke treatment in the aged brain. Curr Neurovasc Res (2015) 0.77

Granulocyte Colony Stimulating Factor and Physiotherapy after Stroke: Results of a Feasibility Randomised Controlled Trial: Stem Cell Trial of Recovery EnhanceMent after Stroke-3 (STEMS-3 ISRCTN16714730). PLoS One (2016) 0.77

Tips for teachers of evidence-based medicine: understanding odds ratios and their relationship to risk ratios. J Gen Intern Med (2008) 0.89

Association between Beta-Fibrinogen C148T Gene Polymorphism and Risk of Ischemic Stroke in a North Indian Population: A Case-Control Study. Pulse (Basel) (2016) 0.75

Development and implementation of acute stroke care pathway in a tertiary care hospital in India: A cluster-randomized study. Neurol India (2016) 0.75